Funder
Helsinn Therapeutics
Rochester General Hospital Research Institute
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005;53(6):1053–63.
2. Mehta-Shah N, Horwitz SM, Ansell S, et al. NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 1.2021. J Natl Compr Cancer Netw. 2021.
3. Trautinger F, Eder J, Assaf C, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome; Update 2017. Eur J Cancer [Internet]. 2017;77:57–74. https://doi.org/10.1016/j.ejca.2017.02.027.
4. Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol [Internet]. 2018;29:iv30–40. https://doi.org/10.1093/annonc/mdy133.
5. Querfeld C, Pacheco T, Haverkos B, et al. A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-level Patient Volume for Mycosis Fungoides Cutaneous T-cell Lymphoma (MF-CTCL) - a Retrospective Cohort Study. Front Med [Internet]. 2021;8:921
https://www.frontiersin.org/article/10.3389/fmed.2021.679294.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献